List of Tables
Table 1. Eosinophilic Disease Market Trends
Table 2. Eosinophilic Disease Market Drivers & Opportunity
Table 3. Eosinophilic Disease Market Challenges
Table 4. Eosinophilic Disease Market Restraints
Table 5. Global Eosinophilic Disease Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Eosinophilic Disease Revenue Market Share by Company (2019-2024)
Table 7. Global Eosinophilic Disease Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Eosinophilic Disease Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Eosinophilic Disease Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Eosinophilic Disease Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Eosinophilic Disease Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Eosinophilic Disease
Table 13. Global Eosinophilic Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Disease as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Eosinophilic Disease Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Eosinophilic Disease Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Eosinophilic Disease Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Eosinophilic Disease Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Eosinophilic Disease Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Eosinophilic Disease Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Eosinophilic Disease Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Eosinophilic Disease Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Eosinophilic Disease Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Eosinophilic Disease Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Eosinophilic Disease Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Eosinophilic Disease Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Eosinophilic Disease Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Eosinophilic Disease Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Eosinophilic Disease Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Eosinophilic Disease Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Eosinophilic Disease Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Eosinophilic Disease Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Eosinophilic Disease Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Eosinophilic Disease Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Eosinophilic Disease Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Eosinophilic Disease Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Eosinophilic Disease Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Eosinophilic Disease Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Eosinophilic Disease Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Eosinophilic Disease Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Eosinophilic Disease Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Eosinophilic Disease Sales Value by Region (2019-2024) & (%)
Table 44. Global Eosinophilic Disease Sales Value by Region (2025-2030) & (%)
Table 45. Global Eosinophilic Disease Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Eosinophilic Disease Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Eosinophilic Disease Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Eosinophilic Disease Sales Volume by Region (2019-2024) & (%)
Table 49. Global Eosinophilic Disease Sales Volume by Region (2025-2030) & (%)
Table 50. Global Eosinophilic Disease Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Eosinophilic Disease Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Eosinophilic Disease Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Eosinophilic Disease Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Eosinophilic Disease Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Eosinophilic Disease Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Eosinophilic Disease Sales Volume, (2025-2030) & (K Units)
Table 57. Takeda Pharmaceutical Company Limited Company Information
Table 58. Takeda Pharmaceutical Company Limited Introduction and Business Overview
Table 59. Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Takeda Pharmaceutical Company Limited Eosinophilic Disease Product Offerings
Table 61. Takeda Pharmaceutical Company Limited Recent Development
Table 62. Ellodi Pharmaceuticals Company Information
Table 63. Ellodi Pharmaceuticals Introduction and Business Overview
Table 64. Ellodi Pharmaceuticals Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Ellodi Pharmaceuticals Eosinophilic Disease Product Offerings
Table 66. Ellodi Pharmaceuticals Recent Development
Table 67. Bristol-Myers Squibb Company Company Information
Table 68. Bristol-Myers Squibb Company Introduction and Business Overview
Table 69. Bristol-Myers Squibb Company Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Bristol-Myers Squibb Company Eosinophilic Disease Product Offerings
Table 71. Bristol-Myers Squibb Company Recent Development
Table 72. AstraZeneca Company Information
Table 73. AstraZeneca Introduction and Business Overview
Table 74. AstraZeneca Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. AstraZeneca Eosinophilic Disease Product Offerings
Table 76. AstraZeneca Recent Development
Table 77. GSK plc Company Information
Table 78. GSK plc Introduction and Business Overview
Table 79. GSK plc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. GSK plc Eosinophilic Disease Product Offerings
Table 81. GSK plc Recent Development
Table 82. Regeneron Pharmaceuticals Inc Company Information
Table 83. Regeneron Pharmaceuticals Inc Introduction and Business Overview
Table 84. Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Regeneron Pharmaceuticals Inc Eosinophilic Disease Product Offerings
Table 86. Regeneron Pharmaceuticals Inc Recent Development
Table 87. Allakos Inc Company Information
Table 88. Allakos Inc Introduction and Business Overview
Table 89. Allakos Inc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Allakos Inc Eosinophilic Disease Product Offerings
Table 91. Allakos Inc Recent Development
Table 92. Arena Pharmaceuticals Ltd Company Information
Table 93. Arena Pharmaceuticals Ltd Introduction and Business Overview
Table 94. Arena Pharmaceuticals Ltd Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Arena Pharmaceuticals Ltd Eosinophilic Disease Product Offerings
Table 96. Arena Pharmaceuticals Ltd Recent Development
Table 97. Revolo Biotherapeutics Company Information
Table 98. Revolo Biotherapeutics Introduction and Business Overview
Table 99. Revolo Biotherapeutics Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Revolo Biotherapeutics Eosinophilic Disease Product Offerings
Table 101. Revolo Biotherapeutics Recent Development
Table 102. DBV Technologies Company Information
Table 103. DBV Technologies Introduction and Business Overview
Table 104. DBV Technologies Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. DBV Technologies Eosinophilic Disease Product Offerings
Table 106. DBV Technologies Recent Development
Table 107. Cipla Inc Company Information
Table 108. Cipla Inc Introduction and Business Overview
Table 109. Cipla Inc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Cipla Inc Eosinophilic Disease Product Offerings
Table 111. Cipla Inc Recent Development
Table 112. Sun Pharmaceutical Industries Ltd Company Information
Table 113. Sun Pharmaceutical Industries Ltd Introduction and Business Overview
Table 114. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Product Offerings
Table 116. Sun Pharmaceutical Industries Ltd Recent Development
Table 117. Sanofi Company Information
Table 118. Sanofi Introduction and Business Overview
Table 119. Sanofi Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Sanofi Eosinophilic Disease Product Offerings
Table 121. Sanofi Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Eosinophilic Disease Downstream Customers
Table 125. Eosinophilic Disease Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Disease Product Picture
Figure 2. Global Eosinophilic Disease Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Eosinophilic Disease Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Eosinophilic Disease Sales Volume (2019-2030) & (K Units)
Figure 5. Global Eosinophilic Disease Sales Price (2019-2030) & (US$/Unit)
Figure 6. Eosinophilic Disease Report Years Considered
Figure 7. Global Eosinophilic Disease Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Eosinophilic Disease Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Eosinophilic Disease Revenue in 2023
Figure 10. Eosinophilic Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Corticosteroids Picture
Figure 12. Monoclonal Antibodies Picture
Figure 13. Anti-cytokine Drug Picture
Figure 14. Cytotoxic Drug Picture
Figure 15. Global Eosinophilic Disease Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Eosinophilic Disease Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Eosinophilic Disease Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Eosinophilic Disease Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Eosinophilic Disease Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Eosinophilic Esophagitis
Figure 21. Product Picture of Eosinophilic Granulomatosis with Polyangiitis
Figure 22. Product Picture of Hyper-eosinophilic Syndrome
Figure 23. Product Picture of Nasal Polyposis
Figure 24. Product Picture of Other
Figure 25. Global Eosinophilic Disease Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Eosinophilic Disease Sales Value Market Share by Application, 2023 & 2030
Figure 27. Global Eosinophilic Disease Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 28. Global Eosinophilic Disease Sales Volume Market Share by Application, 2023 & 2030
Figure 29. Global Eosinophilic Disease Price by Application (2019-2030) & (US$/Unit)
Figure 30. North America Eosinophilic Disease Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Eosinophilic Disease Sales Value by Country (%), 2023 VS 2030
Figure 32. Europe Eosinophilic Disease Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Eosinophilic Disease Sales Value by Country (%), 2023 VS 2030
Figure 34. Asia Pacific Eosinophilic Disease Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Eosinophilic Disease Sales Value by Country (%), 2023 VS 2030
Figure 36. South America Eosinophilic Disease Sales Value (2019-2030) & (US$ Million)
Figure 37. South America Eosinophilic Disease Sales Value by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Eosinophilic Disease Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Eosinophilic Disease Sales Value by Country (%), 2023 VS 2030
Figure 40. Key Countries/Regions Eosinophilic Disease Sales Value (%), (2019-2030)
Figure 41. Key Countries/Regions Eosinophilic Disease Sales Volume (%), (2019-2030)
Figure 42. United States Eosinophilic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 43. United States Eosinophilic Disease Sales Value by Type (%), 2023 VS 2030
Figure 44. United States Eosinophilic Disease Sales Value by Application (%), 2023 VS 2030
Figure 45. Europe Eosinophilic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 46. Europe Eosinophilic Disease Sales Value by Type (%), 2023 VS 2030
Figure 47. Europe Eosinophilic Disease Sales Value by Application (%), 2023 VS 2030
Figure 48. China Eosinophilic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 49. China Eosinophilic Disease Sales Value by Type (%), 2023 VS 2030
Figure 50. China Eosinophilic Disease Sales Value by Application (%), 2023 VS 2030
Figure 51. Japan Eosinophilic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 52. Japan Eosinophilic Disease Sales Value by Type (%), 2023 VS 2030
Figure 53. Japan Eosinophilic Disease Sales Value by Application (%), 2023 VS 2030
Figure 54. South Korea Eosinophilic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 55. South Korea Eosinophilic Disease Sales Value by Type (%), 2023 VS 2030
Figure 56. South Korea Eosinophilic Disease Sales Value by Application (%), 2023 VS 2030
Figure 57. Southeast Asia Eosinophilic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 58. Southeast Asia Eosinophilic Disease Sales Value by Type (%), 2023 VS 2030
Figure 59. Southeast Asia Eosinophilic Disease Sales Value by Application (%), 2023 VS 2030
Figure 60. India Eosinophilic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 61. India Eosinophilic Disease Sales Value by Type (%), 2023 VS 2030
Figure 62. India Eosinophilic Disease Sales Value by Application (%), 2023 VS 2030
Figure 63. Eosinophilic Disease Industrial Chain
Figure 64. Eosinophilic Disease Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
